Normobaric Oxygen Therapy in Colorectal Cancer Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

254

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

November 1, 2027

Study Completion Date

November 1, 2028

Conditions
Colorectal Cancer (CRC)
Interventions
DEVICE

Normobaric oxygen therapy

Patient's exposure to NBO conditions in group 1 (aNBO) including: oxygen levels of 32-40% (compared to about 21% in the atmosphere), pressure maintained at 1,500 hPa (about 1,000 hPa outside), carbon dioxide levels between 0.7-1.9% (compared to 0.03% in the atmosphere, and hydrogen levels between 0.5-1% (which is 10 to 20 thousand times higher than in the atmosphere). Exposure time in the NBO chamber will be the standard 2 hours with an additional 20 minutes for preparation and adaptation and 10 minutes for finalization and the decompression period.

DEVICE

Normobaric oxygen therapy

Patients' exposure to atmospheric conditions in the same NBO chamber (without normobaric conditions to provide placebo intervention as the study comparator) in group 2 (pNBO): oxygen levels about 21%, pressure maintained at about 1,000 hPa, carbon dioxide levels about o 0.03%, and hydrogen levels about 0.00005% (0.5 parts per million, like in the atmos-phere).

Trial Locations (1)

50-981

4th Military Clinical Hospital, Wroclaw

All Listed Sponsors
collaborator

Wroclaw Medical University (Poland)

UNKNOWN

collaborator

Wroclaw University of Science and Technology (Poland)

UNKNOWN

collaborator

Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences (Poland)

UNKNOWN

collaborator

WSB Merito University in Opole (Poland)

UNKNOWN

collaborator

Academy of Applied Sciences in Nowy Sacz (Poland)

UNKNOWN

lead

4th Military Clinical Hospital with Polyclinic, Poland

OTHER